Ashwagandha for Women Over 50: Safety, Dosage, and Hormone Effects Reviewed

I received more reader questions about Ashwagandha than any other herb in the past year, and the majority came from women over 50. The questions were serious and practical: Is it safe with thyroid medication? Does it affect oestrogen? Can it interfere with the hormonal shifts of menopause? Is it the same as taking hormone therapy? And if you feel better on it but your doctor is concerned, how should you decide?

I want to give you real answers, not blanket reassurance. Ashwagandha is a major Ayurvedic Rasayana herb and a widely used adaptogen, with human clinical data for stress and sleep and smaller trials for menopausal symptoms. It is also not appropriate for every woman over 50, especially when thyroid disease, autoimmune disease, liver disease, sedative medicines, blood pressure medicines, diabetes medicines, or hormone therapy are part of the picture.

What Ashwagandha Actually Does Around Menopause

Ashwagandha is best understood as a supportive Rasayana and adaptogenic root, not as an oestrogen tablet, progesterone, testosterone, or hormone replacement therapy. Its most consistent modern use is for stress resilience, sleep, fatigue, and nervous-system steadiness; in small menopause trials, reproductive hormone markers also changed alongside symptom scores.

In a randomized, double-blind, placebo-controlled trial published in 2021, 91 perimenopausal women aged 45–55 received either Ashwagandha root extract or placebo for eight weeks. The Ashwagandha group used 300 mg twice daily and had greater improvement in total Menopause Rating Scale scores, including hot-flash symptoms; serum estradiol increased, while follicle-stimulating hormone and luteinizing hormone decreased, and testosterone did not differ significantly from placebo.

A later randomized, double-blind, placebo-controlled trial in 60 women aged 45–55 used KSM-66 Ashwagandha root extract at 300 mg twice daily for 56 days. Participants taking Ashwagandha had improvement in psychological, somatic, and urogenital Menopause Rating Scale domains, fewer hot-flash events, improved perceived stress and quality-of-life scores, increased estradiol and progesterone, and reduced FSH and LH compared with placebo.

A 24-week randomized trial in post-menopausal women aged 40–55 evaluated standardized Ashwagandha and Shatavari extracts in separate and combined arms. Women receiving Ashwagandha extract had dose-related improvements in menopause-specific quality-of-life scores and markers related to vascular function, bone turnover, inflammation, and oxidative stress. This supports Ashwagandha as a potentially useful menopause-support herb, but not as a replacement for medical evaluation or prescribed hormone therapy.

The Thyroid Question: The Most Important Safety Concern

This is the point most likely to change whether Ashwagandha is reasonable for you. In a double-blind, placebo-controlled trial of 50 adults with subclinical hypothyroidism, Ashwagandha root extract at 300 mg twice daily for eight weeks lowered TSH and increased T3 and T4 compared with placebo. That means Ashwagandha can move thyroid markers; it is not a neutral bedtime herb for everyone.

For women over 50 taking levothyroxine or other thyroid hormone: Ashwagandha may add to the effect of thyroid medication. Do not start it quietly and then interpret new symptoms in isolation. A sensible plan is to discuss it with the prescribing clinician, check baseline thyroid labs if needed, and repeat TSH, free T4, and sometimes T3 after about 6–8 weeks. Palpitations, tremor, anxiety, insomnia, heat intolerance, unexplained weight loss, or a suddenly racing pulse should be treated as warning signs.

For women with hyperthyroidism, Graves’ disease, thyroiditis with suppressed TSH, or a history of thyrotoxicosis: Ashwagandha should not be used as self-care. Case reports describe thyrotoxicosis in women taking Ashwagandha extract, with symptoms resolving after discontinuation. Use in this setting should happen only if an endocrinologist specifically approves it.

For women with normal thyroid labs: Ashwagandha may still be appropriate, but “normal thyroid” should not be used as a permanent guarantee. Women over 50 often have changing thyroid requirements, and new palpitations, agitation, sweating, insomnia, or weight changes after starting Ashwagandha deserve prompt review.

Hormone Replacement Therapy and Compounded Hormones

Ashwagandha should not be treated as a substitute for HRT. Menopausal hormone therapy remains the established medical treatment for bothersome vasomotor symptoms in eligible women, with decisions based on age, time since menopause, symptoms, risk factors, route, dose, and duration. Ashwagandha belongs in a different category: a supportive herb that may help stress, sleep, fatigue, and some menopausal symptoms, while also having measurable endocrine activity in small trials.

Women using systemic oestrogen, progesterone, vaginal oestrogen, compounded “bioidentical” hormones, DHEA, testosterone, or other endocrine-active supplements should treat Ashwagandha as a monitored addition. Track hot flushes, sleep, mood, breast tenderness, bleeding, pelvic symptoms, palpitations, and thyroid-like symptoms during the first 6–8 weeks, and report unexpected changes to the prescribing clinician.

The Safety Profile in Older Women

Most short-term clinical trials describe Ashwagandha as generally well tolerated, with common side effects such as drowsiness, nausea, loose stools, and stomach discomfort. The longer-term safety picture is less settled, and women over 50 are more likely to be taking medications or to have thyroid, autoimmune, liver, blood pressure, blood sugar, or sleep-related conditions that change the risk calculation.

• Autoimmune disease: Ashwagandha can stimulate immune activity. Women with rheumatoid arthritis, lupus, multiple sclerosis, Hashimoto’s thyroiditis, inflammatory bowel disease, transplant history, or immunosuppressant therapy should use it only with clinician guidance.
• Blood pressure and blood sugar medicines: Interaction warnings exist for antihypertensive and antidiabetes medicines. If you use these medicines, monitor blood pressure or glucose more closely when starting or changing the dose.
• Sedatives and sleep medicines: Ashwagandha can cause drowsiness and may have additive effects with benzodiazepines, barbiturates, anticonvulsants, prescription sleep medicines, alcohol, and other calming supplements.
• Liver safety: Rare clinically apparent liver injury has been reported with commercial products labelled as containing Ashwagandha. The typical pattern appears within 2–12 weeks and may include jaundice, itching, dark urine, nausea, abdominal discomfort, fatigue, or abnormal liver tests. Women with cirrhosis or advanced chronic liver disease should avoid it unless a specialist specifically advises otherwise.
• Pregnancy and breastfeeding: Although this is uncommon in the over-50 audience, pregnant or breastfeeding women should not use Ashwagandha without medical guidance.

Finding the Right Dose for You

Dose should be matched to the person, the preparation, the goal, and the safety context. The table below is a practical guide, not a prescription. For women over 50, it is usually wiser to start low, reassess after 6–8 weeks, and stop if symptoms move in the wrong direction.

Form Matters: What to Buy

Not all Ashwagandha products are equivalent. A useful label should tell you the botanical name, plant part, amount per serving, extract ratio or standardization, and whether the product is root-only or root-and-leaf. The root and leaf differ chemically, so one extract should not automatically be treated as interchangeable with another.

• Standardized root extract: KSM-66 is a root-only extract used in menopause and sleep trials, often at 300 mg twice daily, standardized to more than 5% withanolides in the cited clinical product.
• Root-and-leaf extracts: Some products and trials use root-and-leaf preparations. These may have different potency and tolerability from root-only extracts, so follow the label and avoid assuming the same dose applies.
• Traditional root powder: The Ayurvedic Pharmacopoeia of India lists 3–6 g of Ashwagandha root powder as the classical dose, while the Health Canada monograph lists 2–6 g dried root per day for traditional Ayurvedic claims.

Choose single-ingredient, clearly labelled, third-party tested products when possible. Avoid vague proprietary blends if you are trying to understand whether Ashwagandha is helping or causing side effects, especially when thyroid or liver monitoring is relevant.

What Ayurveda Actually Says About Ashwagandha for Older Women

The Ayurvedic Pharmacopoeia of India defines Ashvagandha as the dried mature root of Withania somnifera Dunal. It lists its constituents as alkaloids and withanolides, its rasa as Tikta and Kashaya, guna as Laghu, virya as Ushna, vipaka as Madhura, and karma as Rasayana, Vatakaphapaha, Balya, and Vajikarana. Its therapeutic uses include Shotha, Kshaya, Daurbalya, Vataroga, and Klaibya.

In plain clinical language, Ashwagandha is classically a strengthening, rebuilding, Vata-Kapha balancing root used where depletion, weakness, wasting, and Vata-type disturbance are part of the picture. For a woman over 50, this makes it most relevant when menopause is accompanied by poor sleep, nervous exhaustion, muscle loss, low resilience, and a depleted feeling. Its Ushna virya also means it is not universally cooling or neutral; the same warming and stimulating quality that can help one woman may aggravate another, especially when thyroid heat, palpitations, inflammatory activity, or liver vulnerability is present.

The Bottom Line for Women Over 50

Ashwagandha can be a valuable menopause-support herb when the pattern is stress, sleep disruption, fatigue, Vata-type depletion, and reduced resilience. It is not HRT, not a substitute for medical care, and not an herb to add casually on top of thyroid medication or complex hormone regimens.

• It is most suitable when thyroid function is stable, liver health is good, autoimmune disease is absent or quiet, and medication interactions have been reviewed.
• It should be used cautiously with thyroid hormone, HRT, blood pressure medicines, blood sugar medicines, sedatives, immunosuppressants, and any history of liver disease.
• It should be avoided as self-care in hyperthyroidism, Graves’ disease, thyrotoxicosis, advanced liver disease, active autoimmune disease, pregnancy, and breastfeeding.
• If you feel better on Ashwagandha but your doctor is concerned, do not frame it as Ayurveda versus medicine. Track symptoms, check the relevant labs, and make the decision with a qualified Ayurvedic practitioner and your healthcare provider.

For related reading, see Ashwagandha dosage and low-dose study updates, our guide to the Ayurvedic perimenopause 7-year protocol, and post-menopausal Ayurvedic self-care protocols.

References

1. Ayurvedic Pharmacopoeia of India
2. Webprod (webprod.hc-sc.gc.ca)
3. NIH Office of Dietary Supplements
4. Obgyn (obgyn.onlinelibrary.wiley.com)
5. Frontiersin (frontiersin.org)
6. Ashwagandha and Shatavari Extracts Dose-Dependently Reduce Menopause Symptoms, Vascular Dysfunction, and Bone Resorption in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Study (2025), PubMed Central
7. Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial (2018), PubMed
8. Mskcc (mskcc.org)
9. Mskcc (mskcc.org)
10. NCBI
11. Menopause (menopause.org)